The health sector was supported by 43% of companies and received an average of 7% of CSI expenditure in 2022. This is significantly down from 2010 when 64% of companies supported the sector and it received 17% of CSI spend.
The health sector has experienced a downward trend in support from companies, firstly due to the government improving its HIV/Aids response and, more recently, as the pandemic eases. Within the sector, support for primary healthcare has increased significantly, from 46% of average health expenditure in 2010 to 82% in 2022, with a corresponding decrease in support for secondary and tertiary healthcare. The share of funding dedicated to HIV/Aids has steadily declined, while spend on wellbeing initiatives and training was increasing pre-pandemic. Post-pandemic, we anticipate a return to that trend, and as the population ages, we anticipate greater emphasis on non- communicable diseases.
Level of healthcare
- Primary healthcare continues to account for the largest proportion of CSI healthcare spend (82%), the allocation in 2022 being the highest ever.
- The average healthcare spend allocated to secondary healthcare reduced to 6% in 2022, from 15% in 2021, while the spend on tertiary healthcare was unchanged (12%).
Type of intervention
- Covid-19-related interventions continue to receive the largest share of CSI healthcare spend (32%), though down from 39% in 2021.
- One-quarter of the CSI healthcare spend (25%) went to healthcare education, training and capacity building, an increase from 17% in 2021.
- Expenditure on infrastructure, facilities and equipment increased from 8% in 2021 to 14% in 2022.
- Funding for the other interventions declined in 2022 compared to 2021.
